Inventor · disambiguated record
Thomas R. Coolidge
Also filed as: COOLIDGE THOMAS R
23 granted patents·4 pending applications·1,209 citations·filing 1989–2010
97Inventor score
Files withAMYLIN PHARMACEUTICALS INC12BIONEBRASKA INC8UNIV NEBRASKA2COOLIDGE THOMAS R1UNIV NEBRASKA AND BIONEBRASKA1
Top patents by PatentIndex Score
27 records- 0197US6982248B2Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissueAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Jan 3, 2006·78 cites·28 claims
- 0297US6706689B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Mar 16, 2004·142 cites·41 claims
- 0397US6284725B1Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissueBIONEBRASKA INC·Filed 1999·Granted Sep 4, 2001·186 cites·13 claims
- 0496US6894024B2Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptideAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted May 17, 2005·91 cites·9 claims
- 0595US7888314B2Compositions and methods for treating peripheral vascular diseaseAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Feb 15, 2011·22 cites·8 claims
- 0695US7056887B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Jun 6, 2006·59 cites·12 claims
- 0793US7259136B2Compositions and methods for treating peripheral vascular diseaseAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Aug 21, 2007·40 cites·11 claims
- 0891US8551947B2Treatment of hibernating myocardium with an exendin peptideCOOLIDGE THOMAS R·Filed 2010·Granted Oct 8, 2013·14 cites·12 claims
- 0991US7981861B2Method of performing angioplasty with a GLP-1 moleculeAMYLIN PHARMACEUTICALS INC·Filed 2010·Granted Jul 19, 2011·14 cites·8 claims
- 1091US6998387B1Human appetite control by glucagon-like peptide receptor binding compoundsAMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Feb 14, 2006·160 cites·19 claims
- 1191US5221736ASequential peptide and oligonucleotide syntheses using immunoaffinity techniquesBIONEBRASKA INC·Filed 1989·Granted Jun 22, 1993·77 cites·33 claims
- 1288US6429197B1Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brainBIONEBRASKA INC·Filed 1999·Granted Aug 6, 2002·68 cites·10 claims
- 1385USRE41288EMetabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brainAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Apr 27, 2010·18 cites·29 claims
- 1485US5595887APurification directed cloning of peptides using carbonic anhydrase as the affinity binding segmentBIONEBRASKA INC·Filed 1990·Granted Jan 21, 1997·64 cites·25 claims
- 1575US5464759ASequential oligonucleotide syntheses using immunoaffinity techniquesBIONEBRASKA INC·Filed 1993·Granted Nov 7, 1995·31 cites·2 claims
- 1672US5635371AChemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereofBIONEBRASKA INC·Filed 1994·Granted Jun 3, 1997·34 cites·17 claims
- 1771US7265087B1Exendin improves β-cell response in subjects with impaired glucose toleranceAMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Sep 4, 2007·39 cites·14 claims
- 1869US5656456AChemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereofBIONEBRASKA INC·Filed 1995·Granted Aug 12, 1997·20 cites·24 claims
- 1963US5279954AExopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteinsUNIV NEBRASKA AND BIONEBRASKA·Filed 1989·Granted Jan 18, 1994·17 cites·40 claims
- 2058US2006128627A1Human appetite control by glucagon-like peptide receptor binding compoundsAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2157US2005096276A1Treatment of hibernating myocardium with a GLP-1 peptideFiled 2004·Application pending·0 cites
- 2257US2006035836A1Treatment of acute coronary syndrome with an exendinAMYLIN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2356US2002147131A1Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissueFiled 2001·Application pending·0 cites
- 2452US5234820AExopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteinsUNIV NEBRASKA·Filed 1990·Granted Aug 10, 1993·13 cites·7 claims
- 2551US6127150APurification cloning of peptidesBIONEBRASKA INC·Filed 1997·Granted Oct 3, 2000·5 cites·20 claims
- 2649US5700775AMethod and treatment composition for decreasing patient time in catabolic state after traumatic injuryFiled 1995·Granted Dec 23, 1997·12 cites·20 claims
- 2744US5741686AExopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteinsUNIV NEBRASKA·Filed 1994·Granted Apr 21, 1998·5 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Thomas R. Coolidge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →